Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

GATIFLOXACIN vs GEMCITABINE: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

GATIFLOXACIN vs GEMCITABINE: Safety Overview

Metric GATIFLOXACIN GEMCITABINE
Total FAERS Reports 341 31,328
Deaths Reported 7 5,142
Death Rate 2.1% 16.4%
Hospitalizations 30 12,268
Average Patient Age 62.5 yrs 61.2 yrs
% Female Patients 76.2% 48.4%
FDA Approval Date Aug 19, 2011 Apr 11, 2016
Manufacturer Allergan, Inc. Hikma Pharmaceuticals USA Inc.
Route OPHTHALMIC INTRAVENOUS
Marketing Status Discontinued Discontinued